These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26048514)

  • 1. Detailed characterization of incretin cell distribution along the human small intestine.
    Guedes TP; Martins S; Costa M; Pereira SS; Morais T; Santos A; Nora M; Monteiro MP
    Surg Obes Relat Dis; 2015; 11(6):1323-31. PubMed ID: 26048514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
    Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
    Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential GIP/GLP-1 intestinal cell distribution in diabetics' yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length.
    Palha AM; Pereira SS; Costa MM; Morais T; Maia AF; Guimarães M; Nora M; Monteiro MP
    J Cell Biochem; 2018 Sep; 119(9):7506-7514. PubMed ID: 29761876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine.
    Damholt AB; Kofod H; Buchan AM
    Cell Tissue Res; 1999 Nov; 298(2):287-93. PubMed ID: 10571117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of K and L cells in the feline intestinal tract.
    Gilor C; Gilor S; Graves TK; Borst LB; Labelle P; Ridge TK; Santoro D; Dossin O
    Domest Anim Endocrinol; 2013 Jul; 45(1):49-54. PubMed ID: 23751572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individuals with type 2 diabetes have higher density of small intestinal neurotensin-expressing cells.
    Ferreira FP; Pereira SS; Costa MM; Guimarães M; Albrechtsen NJW; Holst JJ; Nora M; Monteiro MP
    Mol Cell Biochem; 2023 Dec; 478(12):2779-2787. PubMed ID: 36920577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia.
    Nguyen NQ; Debreceni TL; Bambrick JE; Chia B; Wishart J; Deane AM; Rayner CK; Horowitz M; Young RL
    J Clin Endocrinol Metab; 2015 Mar; 100(3):968-76. PubMed ID: 25423571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
    Opinto G; Natalicchio A; Marchetti P
    Arch Physiol Biochem; 2013 Oct; 119(4):170-8. PubMed ID: 23859800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretin hormones and beta cell function in chronic pancreatitis.
    Knop FK
    Dan Med Bull; 2010 Jul; 57(7):B4163. PubMed ID: 20591345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional specificity of the gut-incretin response to small intestinal glucose infusion in healthy older subjects.
    Rigda RS; Trahair LG; Little TJ; Wu T; Standfield S; Feinle-Bisset C; Rayner CK; Horowitz M; Jones KL
    Peptides; 2016 Dec; 86():126-132. PubMed ID: 27780735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones (incretins) on glucose metabolism].
    Matuszek B; Lenart-Lipińska M; Nowakowski A
    Endokrynol Pol; 2007; 58(6):522-8. PubMed ID: 18205109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteroendocrine K and L cells in healthy and type 2 diabetic individuals.
    Jorsal T; Rhee NA; Pedersen J; Wahlgren CD; Mortensen B; Jepsen SL; Jelsing J; Dalbøge LS; Vilmann P; Hassan H; Hendel JW; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2018 Feb; 61(2):284-294. PubMed ID: 28956082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on incretin hormones.
    Phillips LK; Prins JB
    Ann N Y Acad Sci; 2011 Dec; 1243():E55-74. PubMed ID: 22545749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.
    Spielman LJ; Gibson DL; Klegeris A
    Eur J Cell Biol; 2017 May; 96(3):240-253. PubMed ID: 28336086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
    Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.